Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer.
- Resource Type
- Article
- Source
- Breast; Feb2023, Vol. 67, p94-101, 8p
- Subject
HER2 positive breast cancer DIARRHEA METASTATIC breast cancer PROTEIN-tyrosine kinase inhibitors QUALITY of life - Language
- ISSN
- 09609776